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ABSTRACT
Study Design: This was a retrospective, observational study.
Objectives: We hypothesize that the expandable transforaminal lumbar interbody fusion (TLIF) cage achieves satisfactory clinical outcomes 
while allowing for safe placement, improvement, and maintenance of foraminal and disc dimensions at 24 months postsurgery with low risk of 
cage migration, subsidence, and nerve injury.
Methods: TLIF with expandable cages was performed in 54 patients (62 levels) over a 24‑month‑period using open midline or minimally 
invasive surgery techniques with placement of Globus Caliber, Rise, or Altera expandable cages. All patients underwent clinical and radiological 
assessment at 6 weeks, 6 months, 1, and 2 years postoperatively. Clinical outcome was measured by Oswestry disability index (ODI), visual 
analog pain score for both back and leg (visual analog scores [VASs]). Radiological assessment was done by X‑ray standing lateral position.
Results: There were significant clinical improvements in ODI, VAS leg, and VAS back at all postoperative time points. Disc height, foraminal 
height, focal Cobb angle, and global Cobb angle were significantly increased and maintained at all time points for 24 months (P < 0.001). Dural 
tear occurred in one patient (1.9%). There were neither intra‑ or postoperative neurological complications nor cage subsidence nor migration.
Conclusions: These preliminary results indicate that the use of an expandable interbody cage achieves good clinical outcomes by improving 
and maintaining foraminal dimensions and disc height with minimal complication rate.
Keywords: Back pain, expandable interbody cage, interbody fusion, transforaminal lumbar interbody fusion
INTRODUCTION
Posterior lumbar fusion (PLF) is a common surgical 
method of treating patients with spinal back and leg 
pain secondary to instability and stenosis. If performed 
with interbody grafting, it may improve fusions rates, 
restoration of spinal canal dimensions, and lumbar lordosis 
which in turn may improve pain and clinical outcomes.[1] 
Interbody grafting can be performed through posterior 
lumbar interbody fusion (PLIF), lateral lumbar interbody 
fusion (LLIF), and anterior lumbar interbody fusion (ALIF) 
approaches.[2] Transforaminal approaches transforaminal 
lumbar interbody fusion (TLIF) has the benefit of being 
placed through a single posterior approach through a 
unilateral corridor and not requiring an approach close to 
the vascular structures. However, due to the narrow neural 
corridor, it is associated with an increased risk of dural 
injury[3] and compromised cage size, leading to increased 
risk of cage subsidence.[4]
The more recently developed expandable TLIF cages have the 
potential advantages of less neurological injury as well as less 
impaction needed while inserting the cage. Furthermore, the 
more line to line fit of the cage after expansion may allow 
for greater indirect decompression as well as less risk of 
cage migration and subsidence. The counterargument is that 
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the process of expansion may increase the risk of endplate 
damage and hence subsidence. Furthermore, the expansion 
may leave a void across which fusion may not occur and 
therefore may compromise fusion rates.
Despite over 100,000 expandable TLIF cages being implanted 
worldwide, this study to our knowledge is the largest 2‑year 
follow‑up single‑surgeon series in one spine centre relating 
to the expandable TLIF. The objective of this study is to 
show that clinical outcomes and radiographic assessments 
improved postsurgery and that these improvements 
were maintained at 24 months postsurgery with minimal 
complication rate.
METHODS
A total of 62 expandable cage TLIFs were undertaken in 
54 patients by one surgeon at one spinal unit between 
December 2013 and December 2015. There were three types 
of expandable cage included in this study: Globus Caliber, Rise, 
or Altera. The minimum follow‑up was 1 year clinically and 
radiologically, and the maximum follow‑up was 3 years (average 
follow‑up is 23.5 months). All patients underwent clinical 
and radiological assessment at 6 weeks, 6 months, 1 years, 
and 2 years postoperatively. The preoperative patients’ 
demographics are summarized in Table 1.
The patients fulfilled the following criteria: persistent 
stenotic leg pain more than 6 months with failed conservative 
treatment; radiological evidence of foraminal stenosis 
and/or spondylolisthesis with presence of spinal canal 
stenosis; and complete medical records. Data were collected 
retrospectively, using the preoperative hospital admission 
sheets, operative notes, postoperative follow‑up, outpatient 
clinic documentations, and the British Spine Registry. Neither 
Institutional Review Board approval nor other similar entity 
approval was needed.
Surgical procedure
Antibiotics are administered. The patient is positioned prone 
on a Jackson table with pads. Fluoroscopy image intensifier 
guidance is used as deemed appropriate. In the context of 
unilateral leg pain secondary to foraminal stenosis, a minimally 
invasive procedure is performed with percutaneous pedicle 
screws and screw‑based retractor (Nuvasive MASTLIF) through 
which the facetectomy, exiting root decompression, and 
discectomy were performed. In the context of bilateral leg pain, 
an open or mini open TLIF is performed (Globus revere pedicle 
or creo mediocortical trajectory screws, respectively). Following 
careful disc and endplate preparation, the size of the expandable 
cage is estimated. Local bone and demineralized bone matrix 
are placed anterior and lateral to the cage and within. Further 
posterolateral graft is also placed. Screws are connected 
with lordotic rods and judicious compression or distraction 
applied to achieve further lordosis or indirect decompression, 
respectively [Figure 1]. Wounds are closed in layers with suction 
drain in situ. All patients are mobilized day 1 postoperatively as 
comfort allowed. Drain and catheter are removed day 1 or 2 
postoperatively. Postoperative standing X‑rays are performed 
before discharge.
Outcome measures
Clinical outcome was assessed using the Oswestry disability 
index (ODI) and visual analog score (VAS) for leg and back 
pain. Radiological assessment was performed blindly by 
one spinal fellow with 5‑year‑experience in spine surgery 
using intraobserver studies over 3‑month period. The 
assessment included as follows: (1) Disc height ratio was 
calculated as the ratio between the disc height and the 
height of the superior vertebral body. Disc height was 
Table 1: Patients’ demographics
Demographic n=54
Mean Age (StD, range) 56.1 (13.1, 33 to 85)
Gender (n, %)
Male 24 (44.4)
Female 30 (55.6)
Smoker (n, %) 3 (5.6)
Diabetes (n, %) 5 (9.3)
Locations and levels (n, %)
1 Level 46 (85.2)
2 Levels 8 (14.8)
L2/3 1 (1.6)
L3/4 5 (8.1)
L4/5 25 (40.3)
L5/S1 31 (50.0)
Figure 1: (a) Cage insertion, (b) Cage distraction, (c) Compression on screws 
to restore lordosis
c
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measured as perpendicular distance between the two 
cartilagenous endplates in the middle of the vertebra 
above. (2)  Neuroforaminal height ratio was measured using 
the ratio with the vertebral body above. Neuroforaminal 
height was measured using line between the middle 
of the edge of superior and inferior pedicles. (3) Local 
Cobb angle (defined as the angle between the upper and 
lower edges of the intervertebral disc) and global Cobb 
angle (defined as the angle between the lower endplate of 
the L5 and the upper endplate of L1) [Figure 2a]. (4) Fusion 
rate was determined using Brantigan and Steffe criteria for 
interbody fusion[5] [Table 2] only solid radiographic fusion is 
counted as Fused. Probable fusion is considered not fused.
Standing Lateral view Dorsolumbar radiographs were 
performed immediately postoperatively and every 6 month 
after surgery for minimum of 2 years.
Statistical analysis
Paired samples t‑tests were conducted to investigate 
whether there was a difference in patient reported pain 
between presurgery, 12 months postsurgery, and 24 months 
post‑surgery, as identified using the ODI, VAS back, and VAS 
leg instruments. Paired samples t‑tests were also conducted 
to investigate whether there was a difference in radiographic 
assessments (intervertebral disc height, neuroforaminal 
height, focal Cobb angle, and global Cobb angle between 
presurgery and 6, 12, and 24 months postsurgery, 
respectively).
RESULTS
The data collected from 54 patients (62 fusion levels as some 
patients had more than one level fusion) of surgically managed 
with expandable cages were analyzed [Table 3]. Nearly 68% 
of patients had 2 years of follow‑up. The average operative 
time was 132 min (126 for single level and 168 for two levels). 
The average blood loss was 167 ml (154 for single level and 
241 for two levels). The average hospital stay was 4 days. 
The complications were as follows: dural tear was noted 
in one patient (1.9%). no deep infection was noted, no root 
injury, no persistent back pain, and neither cage migration 
nor subsidence were reported. There was no significant 
difference between the three cage types used. There was 
also no significant difference between MIS and open surgery.
Clinical outcome
All patients had pain relief by the final follow‑up. Mean ODI 
score improved significantly from 61.4 ± 17 preoperatively 
to 40 ± 18.8 at 12 months postoperatively, to 38.3 ± 22.1 
at 24 months; P < 0.001 in all follow‑ups [Figure 3]. Mean 
back pain VAS improved significantly from 7.7 ± 2.3 
preoperatively to 4.7 ± 2.7 at 12 months postoperatively, to 
Table 2: Description of fusion by Brantigan & Steffee
Fusion grade Description
Obvious radiographic 
pseudoarthrosis:
Collapse of construct, loss of disc height, vertebral 
slip, broken screws or resorption of bone graft.
Probable radiographic 
pseudoarthrosis:
Visible gap or lucency >2mm in the fusion area.
Radiographic status 
uncertain:
A small visible gap with at least half of the graft 
area showing no lucency between the graft 
bone and vertebral bone
Probable Radiographic 
fusion:
Bone bridges the entire fusion area with at least 
the density originally achieved at surgery. There 
should be no lucency between the graft bone 
and vertebral bone.
Radiographic fusion: The bone in the fusion area is more dense 
and more mature than originally achieved in 
surgery, there is no interface between the 
donor bone and vertebral bone ; a sclerotic 
line between the graft and vertebral bone 
indicates solid fusion. Other indicators of solid 
fusion is fusion of the facet joints and anterior 
progression of the graft in the disc 
Table 3: Intra & Postoperative clinical data
Variables Results
Operating Time (mins) (StD, range)
All 132.3 (30.7, 75 to 210)
1 Level 126.0 (26.8, 75 to 200)
2 Levels 168.8 (27.0, 130 to 210)
Blood Loss (mL) (StD, range)
All 167.4 (71.2, 100 to 350)
1 Level 154.6 (63.4, 100 to 350)
2 Levels 241.3 (72.0, 130 to 350)
Complications (n, %)
Dural tear 1 (1.9)
Hospital Length of Stay (days) (StD, range)
All 4.6 (2.2, 1 to 11)
1 Level 4.2 (2.1, 1 to 11)
2 Levels 6.6 (1.7, 4 to 8)
Figure 2: (a) Measuring variable angles and neural dimensions: (1) Red line: 
neuroforaminal height. (2) Blue line: Disc height. (3) Yellow line: Focal and 
Global Cobb angle, (b) Follow‑up X‑ray
ba
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4.6 ± 3.3 at 24 months; P < 0.001 in all follow‑ups [Figure 4]. 
Mean leg pain VAS decreased significantly from 7.8 ± 2.5 
preoperatively to 3.5 ± 2.8 at 12 months postoperatively, to 
3.7 ± 3.2 at 24 months; P < 0.001 in all follow‑ups [Figure 5].
Radiological outcomes
Fusion rate was satisfactory, reaching 93% Grade 5 by 
Brantigan and Steffe classification by 12 months and 
100% by 24 months. Radiological assessment from the 
2‑year follow‑up in 37 patients (41 levels) was as follows: 
intervertebral disc heights changed from 8.8 ± 2.7 
preoperatively to 14 ± 2.2 postoperatively to 13.9 ± 2.1 at 
6 months follow‑up, to 13.6 ± 2.2 at 1 year and 13.3 ± 2.6 at 
2 years. P <0.001in all follow‑ups [Figure 5]. Neuroforaminal 
height changed from 17.4 ± 3.1 preoperatively to 21.3 ± 3 
postoperatively to 20.6 ± 2.7 at 6 months postoperatively, 
to 20.3 ± 2.9 at 1 year and 19 ± 2.7 at 2 years. P <0.001 
in all follow‑ups [Figure 6]. Focal Cobb angle improved from 
7 ± 4.5 preoperatively to 10.2 ± 4.1 postoperatively to 
9.7 ± 3.8 at 6 months follow‑up, to 9.7 ± 4.2 at 1 year and 
7.3 ± 3.3 at 2 years. P <0.001 in all follow‑ups [Figure 7]. 
Global Cobb angle improved from 42.2 ± 15.1 preoperatively 
to 49.4 ± 13.9 postoperatively, to 49.5 ± 13.9 at 6 months 
follow‑up, to 48.9 ± 14.4 at 1 year and 45.4 ± 16 at 2 years; 
P < 0.001 in all follow‑up [Figure 8].
Radiological assessment for 37 patients (41 levels) 
preoperative and at 2 years showed also significant 
maintained improvement in disc height from 8.3 ± 3 to 
13.3 ± 2.6, neuroforaminal height from 17 ± 3.4 to 19 ± 2.7, 
focal Cobb angle from 5.5 ± 4.3 to 7.3 ± 3.3, and global 
Cobb angle from 40.9 ± 15.7 to 45.4 ± 16. P <0.001 in all 
follow‑ups [Table 4].
DISCUSSION
Spinal leg pain may be as a result of disc and foraminal 
collapse compressing the exiting nerve root. In such 
circumstances, an uninstrumented decompression alone 
may not achieve the required root decompression to provide 
leg pain relief. Therefore, a fusion can be performed to 
restore the foraminal dimensions and achieve indirect 
decompression of the root with or without supplemental 
direct decompression. It is also frequently performed in the 
setting of instability and symptomatic spondylolisthesis.[1] 
Several types of lumbar fusion have been performed including 
PLF as well as interbody grafting options from posterior PLIF, 
ALIF, LLIF, and the transforaminal (TLIF) approaches.[2]
Interbody fusion for back pain was pioneered by Cloward 
in 1940, using tricortical iliac graft.[6] In 1985, Cloward 
claimed 87%–92% clinical success and 92% fusion success 
in his 40‑year‑experience.[7] In 1993, Brantigan and Steffee 
Figure 4: Mean visual analog score back pain and leg pain over 24‑month 
follow‑up
Figure 3: Mean Oswestry disability index changes over 24‑month follow‑up
Figure 6: Neuroforaminal height changes over 24 monthsFigure 5: Disc height changes over 24 months
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developed the first interbody synthetic cage which was 
carbon‑fiber‑reinforced implant and achieved 100% fusion 
rate in 26 patients in 2‑year follow‑up.[5]
MIS with lumbar interbody fusion using an interbody cage 
was introduced in 2002 by Foley and Lefkowitz,[8] This surgery 
offered the advantages of the MIS techniques with less 
bleeding, less infection, and less postoperative pain; however, 
the radiological outcome was not statistically different from 
the open TLIF.[3,4,9‑11]
In 2005, McAfee et al. published a retrospective study on 
radiological outcomes of static TLIF cages on 120 patients with 
spondylolisthesis with minimal follow‑up 2 years. The results 
demonstrated that TLIF cages maintained an increase of disc 
height by 68%. Intraoperative complications included dural 
tear in seven patients (5.8%). Revision surgery was needed in 
three patients (2.5%), two due to deep infection (1.6%), and 
one complicated with cage migration (0.8%).[12]
In 2011, Rouben et al. analyzed retrospectively 169 patients 
treated by MIS static TLIF cages for back pain with an average 
follow‑up of 49 months. There was a significant improvement 
in clinical outcome with a fusion rate of 96%. Complications 
were adjacent segment disease in three patients and 
pseudoarthrosis in one patient with a total of four patients 
requiring revision surgery (2.3%).[13]
In 2010, Aoki et al. noted cage migration within 3 months 
of static TLIF in a case series of 125 patients (3.2%). Two of 
them had unilateral fixation. They explained this due to the 
presence of scoliotic curve and undersized cages.[14]
In 2015, Phan et al. systematically reviewed and compared 
ALIF versus TLIF including six electronic databases. The TLIF 
group showed dural tear incidence of 3.8%.[15]
In 2016, Kim et al. published a study about MIS expandable 
cage TLIF on 50 patients demonstrating maintenance 
of disc dimensions in single‑ and double‑level primary 
fixation. There were no significant intraoperative or 
perioperative complications, dural tear, and infection 
reported. Postoperative radiographs showed no evidence of 
cage migration, subsidence, or collapse and suggested fusion 
at all operative levels by 12 months and 24 months (93%, 
97%), respectively.[16] This study highlighted the potential 
benefits of the expandable cage with regard to reduced 
implantation‑related complication rates. However, very few 
further studies exist in the literature.
Our study included 54 patients. There was minimally invasive 
and open surgery with clinical and radiological follow‑up 
for 2 years. The results indicate a similar rate of fusion to 
static cage TLIFs, yet with low complication rate and hospital 
stay while restoring and maintaining the inteverterbral and 
neuroforaminal height, and focal and global Cobb angle 
over 2‑year follow‑up. It is noted that focal Cobb angle 
remains static while Global Cobb angle was less maintained 
due to associated pathology in upper lumbar spine segments 
which is not related to the fusion and nonadjacent segment 
disease [Table 5].
Limitation to the study
It was performed retrospectively with lack of control group. 
Computerized tomography scanning would provide more 
accurate information regarding fusions rates but would 
subject the patient group to increased radiation which we 
felt unnecessary in patients with no clinical indication to be 
scanned.
Table 4: Radiological outcome for 37 patients with 2 year 
follow up preoperatively and at 2 years.
Mean 
(SD) Disc 
height
Mean (SD) 
Neuroforaminal 
height
Mean (SD) 
Focal cobb 
angle
Mean (SD) 
global cobb 
angle
Pre‑ 
operative
8.3 (3.0) 17.0 (3.4) 5.5 (4.3) 40.9 (15.7)
Post‑ 
Operative 
(24m)
13.3 (2.6) 
P<0.001§
19.0 (2.7) 
P=0.001§
7.3 (3.3) 
P=0.001§
45.4 (16.0) 
P=0.001§
Figure 7: Focal Cobb angle changes over 24 months Figure 8: Global Cobb angle changes over 24 months
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CONCLUSIONS
These preliminary results indicate that the use of an 
expandable interbody cage minimizes approach‑related 
neural injury and achieves good clinical as well as radiological 
outcomes by improving and maintaining foraminal 
dimensions and disc height with no evidence of cage 
migration or subsidence in our series. We recommend longer 
term follow‑up and a randomized controlled trial comparing 
expandable with static interbody cages.
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